Plenary: COVID-19 And The Future Clinical Trials Landscape
Leading Insights For The Whole Clinical Trials Community
Clinical Trials Europe Day 1 Plenary
Day 1: 2nd November 2020
11.00 - 17.00
11:20 - 11:40 | Changes and challenges to clinical trials during and after a worldwide pandemic
Janis Little, Vice President, Global R&D Quality, Allergan, USA
11:40 - 12:00 | Biotech experience of the rapid and nimble acceleration of clinical programmes in the light of SARS CoV2
Elizabeth Eagling-Vose, Director, Head of Clinical Operations, Vaccitech, UK
12:00 - 12:20 | Vaccine acceptability
Robert Dingwall, Professor of Sociology, Nottingham Trent University, UK
12:20 - 12:50 | Live Q&A with Plenary Speakers
Janis Little, Vice President, Global R&D Quality, Allergan, USA
Elizabeth Eagling-Vose, Director, Head of Clinical Operations, Vaccitech, UK
Robert Dingwall, Professor of Sociology, Nottingham Trent University, UK
12:50 - 13:50 | Networking Forum and Exhibitor “Meet and Greet”
Take this time to grab some refreshments, connect with colleagues, browse the virtual exhibition hall and meet with fellow attendees.
13:50 - 14:10 | Change of operational model during COVID-19 pandemic
Bodo Lutz, Clinical Risk Management and Data Integrity QA, Novartis, Germany
14:10 - 14:30 | Spotlight Presentation: Effects of an unpredictable pandemic on clinical trials and the need for virtualization
Anthony Costello, Senior Vice President, Medidata, USA
14:30 - 15:00 | Live Q&A with Plenary Speakers
Bodo Lutz, Clinical Risk Management and Data Integrity QA, Novartis, Germany
Anthony Costello, Senior Vice President, Medidata, USA
15:00 - 16:00 | Networking Forum and Exhibitor "Meet and Greet"
16:00 - 17:00 | LIVE Virtual Networking Reception
Clinical Trials Europe Day 3 Plenary
Day 3: 4th November 2020
12:40 - 17:10
12:50 - 13:10 | The drug development paradigm and ways that the pandemic is facilitating major change
Kenneth Getz, Deputy Director and Professor, Tufts Center for the Study of Drug Development Tufts University, USA
13:10 - 13:30 | BREXIT – What impact will this have on clinical trials in the UK?
Sheuli Porkess, Executive Director Research Medical & Innovation, Association of the British Pharmaceutical Industry (ABPI), UK
13:30 - 13:50 | PANEL: The future of clinical trials
Anita Nelson, Senior Vice President, Translational Medicine, Parexel International, UK
13:50 - 14:20 | Live Q&A with Plenary Speakers
Kenneth Getz, Deputy Director and Professor, Tufts Center for the Study of Drug Development Tufts University, USA
Sheuli Porkess, Executive Director Research Medical & Innovation, Association of the British Pharmaceutical Industry (ABPI), UK
Anita Nelson, Senior Vice President, Translational Medicine, Parexel International, UK
14:20 - 15:20 | Networking Forum and Exhibitor “Meet and Greet”
15:20 - 15:30 | Christine Pierre Lifetime Achievement Award in Association with mdgroup
15:30 - 15:40 | Clinical Trials Europe Virtual Exhibition Stand Award Sponsored by PharmaTargeting
15:40 - 16:10 | Inspirational Speaker: Medical Aspects of Space travel
André Kuipers, Astronaut, Physician and Ambassador of the Earth, The Netherlands